Elizabeth Halvorsen
Company: Seres Therapeutics
Job title: Senior Director, Experimental and Translational Biology
Seminars:
Biomarkers of Microbiome Disruption for Patient Stratification in Clinical Trials of Microbiome Therapeutics in IBD 4:30 pm
Microbiome heterogeneity in structural, functional, and immuno-modulatory properties in IBD Baseline biomarkers predictive of microbiome therapeutic pharmacodynamics in IBD Relating microbiome disruption and immuno-modulatory properties to inform patient stratificationRead more
day: Conference Day One